We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

396 hedge funds and large institutions have $8.52B invested in Amedisys in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 148 increasing their positions, 145 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $6.8B → $8.52B (+$1.72B)

9% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 46

2% more repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 145

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% less funds holding

Funds holding: 397396 (-1)

0.32% less ownership

Funds ownership: 89.03%88.71% (-0.32%)

20% less call options, than puts

Call options by funds: $44M | Put options by funds: $54.7M

Holders
396
Holders Change
-1
Holders Change %
-0.25%
% of All Funds
7.01%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
50
Increased
148
Reduced
145
Closed
46
Calls
$44M
Puts
$54.7M
Net Calls
-$10.8M
Net Calls Change
+$10.1M

AMED Hedge Fund Activity: Q4 2020 in Review

396 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2020, worth a combined $8.52B — up 25% from $6.8B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AMED positions and 46 closed out — a net gain of 4 holders — while 148 added to existing stakes and 145 trimmed.

The largest buyer was Invesco, adding an estimated $94.5M. The largest seller was Assenagon Asset Management, cutting an estimated $46.9M.

  • 396 institutional investors held Amedisys (AMED) as of Q4 2020, down from 397 in Q3 2020.
  • Funds reported $8.52B of Amedisys stock for Q4 2020, up 25% quarter-over-quarter.
  • 50 funds opened new Amedisys positions in Q4 2020 and 46 closed out, a net change of +4 holders.
  • The largest Amedisys buyer in Q4 2020 was Invesco, an estimated $94.5M added.
  • The largest Amedisys seller in Q4 2020 was Assenagon Asset Management, an estimated $46.9M sold.

Based on aggregated 13F filings for Q4 2020.